Copyright Reports & Markets. All rights reserved.

Global Injectable Bone Substitute Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Injectable Bone Substitute Product
    • 1.2 Key Market Segments in This Study
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Injectable Bone Substitute Market Size Growth Rate by Type
      • 1.4.2 Natural
      • 1.4.3 Synthetic
    • 1.5 Market by Application
      • 1.5.1 Global Injectable Bone Substitute Market Size Growth Rate by Application
      • 1.5.2 Hospital
      • 1.5.3 Clinic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Injectable Bone Substitute Market Size
      • 2.1.1 Global Injectable Bone Substitute Revenue 2014-2025
      • 2.1.2 Global Injectable Bone Substitute Production 2014-2025
    • 2.2 Injectable Bone Substitute Growth Rate (CAGR) 2019-2025
    • 2.3 Analysis of Competitive Landscape
      • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 2.3.2 Key Injectable Bone Substitute Manufacturers
        • 2.3.2.1 Injectable Bone Substitute Manufacturing Base Distribution, Headquarters
        • 2.3.2.2 Manufacturers Injectable Bone Substitute Product Offered
        • 2.3.2.3 Date of Manufacturers Enter into Injectable Bone Substitute Market
    • 2.4 Key Trends for Injectable Bone Substitute Markets & Products

    3 Market Size by Manufacturers

    • 3.1 Injectable Bone Substitute Production by Manufacturers
      • 3.1.1 Injectable Bone Substitute Production by Manufacturers
      • 3.1.2 Injectable Bone Substitute Production Market Share by Manufacturers
    • 3.2 Injectable Bone Substitute Revenue by Manufacturers
      • 3.2.1 Injectable Bone Substitute Revenue by Manufacturers (2014-2019)
      • 3.2.2 Injectable Bone Substitute Revenue Share by Manufacturers (2014-2019)
    • 3.3 Injectable Bone Substitute Price by Manufacturers
    • 3.4 Mergers & Acquisitions, Expansion Plans

    4 Injectable Bone Substitute Production by Regions

    • 4.1 Global Injectable Bone Substitute Production by Regions
      • 4.1.1 Global Injectable Bone Substitute Production Market Share by Regions
      • 4.1.2 Global Injectable Bone Substitute Revenue Market Share by Regions
    • 4.2 North America
      • 4.2.1 North America Injectable Bone Substitute Production
      • 4.2.2 North America Injectable Bone Substitute Revenue
      • 4.2.3 Key Players in North America
      • 4.2.4 North America Injectable Bone Substitute Import & Export
    • 4.3 Europe
      • 4.3.1 Europe Injectable Bone Substitute Production
      • 4.3.2 Europe Injectable Bone Substitute Revenue
      • 4.3.3 Key Players in Europe
      • 4.3.4 Europe Injectable Bone Substitute Import & Export
    • 4.4 China
      • 4.4.1 China Injectable Bone Substitute Production
      • 4.4.2 China Injectable Bone Substitute Revenue
      • 4.4.3 Key Players in China
      • 4.4.4 China Injectable Bone Substitute Import & Export
    • 4.5 Japan
      • 4.5.1 Japan Injectable Bone Substitute Production
      • 4.5.2 Japan Injectable Bone Substitute Revenue
      • 4.5.3 Key Players in Japan
      • 4.5.4 Japan Injectable Bone Substitute Import & Export

    5 Injectable Bone Substitute Consumption by Regions

    • 5.1 Global Injectable Bone Substitute Consumption by Regions
      • 5.1.1 Global Injectable Bone Substitute Consumption by Regions
      • 5.1.2 Global Injectable Bone Substitute Consumption Market Share by Regions
    • 5.2 North America
      • 5.2.1 North America Injectable Bone Substitute Consumption by Application
      • 5.2.2 North America Injectable Bone Substitute Consumption by Countries
      • 5.2.3 United States
      • 5.2.4 Canada
      • 5.2.5 Mexico
    • 5.3 Europe
      • 5.3.1 Europe Injectable Bone Substitute Consumption by Application
      • 5.3.2 Europe Injectable Bone Substitute Consumption by Countries
      • 5.3.3 Germany
      • 5.3.4 France
      • 5.3.5 UK
      • 5.3.6 Italy
      • 5.3.7 Russia
    • 5.4 Asia Pacific
      • 5.4.1 Asia Pacific Injectable Bone Substitute Consumption by Application
      • 5.4.2 Asia Pacific Injectable Bone Substitute Consumption by Regions
      • 5.4.3 China
      • 5.4.4 Japan
      • 5.4.5 South Korea
      • 5.4.6 India
      • 5.4.7 Australia
      • 5.4.8 Indonesia
      • 5.4.9 Thailand
      • 5.4.10 Malaysia
      • 5.4.11 Philippines
      • 5.4.12 Vietnam
    • 5.5 Central & South America
      • 5.5.1 Central & South America Injectable Bone Substitute Consumption by Application
      • 5.5.2 Central & South America Injectable Bone Substitute Consumption by Country
      • 5.5.3 Brazil
    • 5.6 Middle East and Africa
      • 5.6.1 Middle East and Africa Injectable Bone Substitute Consumption by Application
      • 5.6.2 Middle East and Africa Injectable Bone Substitute Consumption by Countries
      • 5.6.3 Turkey
      • 5.6.4 GCC Countries
      • 5.6.5 Egypt
      • 5.6.6 South Africa

    6 Market Size by Type

    • 6.1 Global Injectable Bone Substitute Production by Type
    • 6.2 Global Injectable Bone Substitute Revenue by Type
    • 6.3 Injectable Bone Substitute Price by Type

    7 Market Size by Application

    • 7.1 Overview
    • 7.2 Global Injectable Bone Substitute Breakdown Dada by Application
      • 7.2.1 Global Injectable Bone Substitute Consumption by Application
      • 7.2.2 Global Injectable Bone Substitute Consumption Market Share by Application (2014-2019)

    8 Manufacturers Profiles

    • 8.1 Wright Medical
      • 8.1.1 Wright Medical Company Details
      • 8.1.2 Company Overview
      • 8.1.3 Wright Medical Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.1.4 Wright Medical Injectable Bone Substitute Product Description
      • 8.1.5 Wright Medical Recent Development
    • 8.2 Zimmer Biomet
      • 8.2.1 Zimmer Biomet Company Details
      • 8.2.2 Company Overview
      • 8.2.3 Zimmer Biomet Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.2.4 Zimmer Biomet Injectable Bone Substitute Product Description
      • 8.2.5 Zimmer Biomet Recent Development
    • 8.3 Medtronic
      • 8.3.1 Medtronic Company Details
      • 8.3.2 Company Overview
      • 8.3.3 Medtronic Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.3.4 Medtronic Injectable Bone Substitute Product Description
      • 8.3.5 Medtronic Recent Development
    • 8.4 SeaSpine
      • 8.4.1 SeaSpine Company Details
      • 8.4.2 Company Overview
      • 8.4.3 SeaSpine Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.4.4 SeaSpine Injectable Bone Substitute Product Description
      • 8.4.5 SeaSpine Recent Development
    • 8.5 DePuy Synthes
      • 8.5.1 DePuy Synthes Company Details
      • 8.5.2 Company Overview
      • 8.5.3 DePuy Synthes Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.5.4 DePuy Synthes Injectable Bone Substitute Product Description
      • 8.5.5 DePuy Synthes Recent Development
    • 8.6 Stryker
      • 8.6.1 Stryker Company Details
      • 8.6.2 Company Overview
      • 8.6.3 Stryker Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.6.4 Stryker Injectable Bone Substitute Product Description
      • 8.6.5 Stryker Recent Development
    • 8.7 Xtant Medical
      • 8.7.1 Xtant Medical Company Details
      • 8.7.2 Company Overview
      • 8.7.3 Xtant Medical Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.7.4 Xtant Medical Injectable Bone Substitute Product Description
      • 8.7.5 Xtant Medical Recent Development
    • 8.8 Graftys
      • 8.8.1 Graftys Company Details
      • 8.8.2 Company Overview
      • 8.8.3 Graftys Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.8.4 Graftys Injectable Bone Substitute Product Description
      • 8.8.5 Graftys Recent Development
    • 8.9 Arthrex
      • 8.9.1 Arthrex Company Details
      • 8.9.2 Company Overview
      • 8.9.3 Arthrex Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.9.4 Arthrex Injectable Bone Substitute Product Description
      • 8.9.5 Arthrex Recent Development
    • 8.10 Biomatlante
      • 8.10.1 Biomatlante Company Details
      • 8.10.2 Company Overview
      • 8.10.3 Biomatlante Injectable Bone Substitute Production Revenue and Gross Margin (2014-2019)
      • 8.10.4 Biomatlante Injectable Bone Substitute Product Description
      • 8.10.5 Biomatlante Recent Development
    • 8.11 Biocomposites
    • 8.12 ORD

    9 Production Forecasts

    • 9.1 Injectable Bone Substitute Production and Revenue Forecast
      • 9.1.1 Global Injectable Bone Substitute Production Forecast 2019-2025
      • 9.1.2 Global Injectable Bone Substitute Revenue Forecast 2019-2025
    • 9.2 Injectable Bone Substitute Production and Revenue Forecast by Regions
      • 9.2.1 Global Injectable Bone Substitute Revenue Forecast by Regions
      • 9.2.2 Global Injectable Bone Substitute Production Forecast by Regions
    • 9.3 Injectable Bone Substitute Key Producers Forecast
      • 9.3.1 North America
      • 9.3.2 Europe
      • 9.3.3 China
      • 9.3.4 Japan
    • 9.4 Forecast by Type
      • 9.4.1 Global Injectable Bone Substitute Production Forecast by Type
      • 9.4.2 Global Injectable Bone Substitute Revenue Forecast by Type

    10 Consumption Forecast

    • 10.1 Injectable Bone Substitute Consumption Forecast by Application
    • 10.2 Injectable Bone Substitute Consumption Forecast by Regions
    • 10.3 North America Market Consumption Forecast
      • 10.3.1 North America Injectable Bone Substitute Consumption Forecast by Regions 2019-2025
      • 10.3.2 United States
      • 10.3.3 Canada
      • 10.3.4 Mexico
    • 10.4 Europe Market Consumption Forecast
      • 10.4.1 Europe Injectable Bone Substitute Consumption Forecast by Regions 2019-2025
      • 10.4.2 Germany
      • 10.4.3 France
      • 10.4.4 UK
      • 10.4.5 Italy
      • 10.4.6 Russia
    • 10.5 Asia Pacific Market Consumption Forecast
      • 10.5.1 Asia Pacific Injectable Bone Substitute Consumption Forecast by Regions 2019-2025
      • 10.5.2 China
      • 10.5.3 Japan
      • 10.5.4 South Korea
      • 10.5.5 India
      • 10.5.6 Australia
      • 10.5.7 Indonesia
      • 10.5.8 Thailand
      • 10.5.9 Malaysia
      • 10.5.10 Philippines
      • 10.5.11 Vietnam
    • 10.6 Central & South America Market Consumption Forecast
      • 10.6.1 Central & South America Injectable Bone Substitute Consumption Forecast by Regions 2019-2025
      • 10.6.2 Brazil
    • 10.7 Middle East and Africa Market Consumption Forecast
      • 10.7.1 Middle East and Africa Injectable Bone Substitute Consumption Forecast by Regions 2019-2025
      • 10.7.2 Turkey
      • 10.7.3 GCC Countries
      • 10.7.4 Egypt
      • 10.7.5 South Africa

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Injectable Bone Substitute Sales Channels
      • 11.2.2 Injectable Bone Substitute Distributors
    • 11.3 Injectable Bone Substitute Customers

    12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Porter’s Five Forces Analysis

    13 Key Findings in the Global Injectable Bone Substitute Study

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Injectable Bone Substitute is a kind of bone substitute used in orthopedic surgical procedure which replaces missing bone in order to repair bone fracture. It can be used through a special syringe.
      The Injectable Bone Substitute market was valued at 208 Million US$ in 2018 and is projected to reach 285.9 Million US$ by 2025, at a CAGR of 4.7% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Injectable Bone Substitute.

      This report presents the worldwide Injectable Bone Substitute market size (value, production and consumption), splits the breakdown (data status 2014-2019 and forecast to 2025), by manufacturers, region, type and application.
      This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

      The following manufacturers are covered in this report:
      Wright Medical
      Zimmer Biomet
      Medtronic 
      SeaSpine
      DePuy Synthes 
      Stryker 
      Xtant Medical
      Graftys 
      Arthrex
      Biomatlante
      Biocomposites
      ORD

      Injectable Bone Substitute Breakdown Data by Type
      Natural
      Synthetic

      Injectable Bone Substitute Breakdown Data by Application
      Hospital
      Clinic

      Injectable Bone Substitute Production by Region
      North America
      Europe
      China
      Japan

      Injectable Bone Substitute Consumption by Region
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Central & South America
      Brazil
      Middle East & Africa
      Turkey
      GCC Countries
      Egypt
      South Africa

      The study objectives are:
      To analyze and research the global Injectable Bone Substitute status and future forecast，involving, production, revenue, consumption, historical and forecast.
      To present the key Injectable Bone Substitute manufacturers, production, revenue, market share, and recent development.
      To split the breakdown data by regions, type, manufacturers and applications.
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Injectable Bone Substitute :
      History Year: 2014 - 2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year: 2019 - 2025

      This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Injectable Bone Substitute market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now